Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2012-08-21 17:40 |
TEST REUSSI POUR LE VIRUS DE BIODIEM SUR LA LIGNEE CELLULAIRE EB66® DE VIVALIS
|
French | 261.6 KB | ||
| 2012-08-03 08:30 |
VIVALIS :ACTIONS ET DROITS DE VOTE JUILLET 2012
|
English | 133.7 KB | ||
| 2012-07-31 17:40 |
VIVALIS ANNONCE LA SIGNATURE D'UN NOUVEL ACCORD POUR LE DEVELOPPEMENT D'UNE NOU…
|
French | 77.0 KB | ||
| 2012-07-31 17:40 |
VIVALIS ANNOUNCES A NEW AND NOVEL EB66® CELL LINE DEVELOPMENT AGREEMENT
|
English | 85.8 KB | ||
| 2012-07-19 17:41 |
VIVALIS ANNOUNCES 2012 SECOND QUARTER REVENUES AND CASH POSITION
|
English | 541.3 KB | ||
| 2012-07-19 17:40 |
VIVALIS PUBLIE SON CHIFFRE D'AFFAIRE ET SA SITUATION DE TRESORERIE POUR LE SECO…
|
French | 261.2 KB | ||
| 2012-07-17 17:40 |
VIVALIS ANNONCE LA SIGNATURE D'UNE NOUVELLE LICENCE DE RECHERCHE AVEC MERIAL LI…
|
French | 214.6 KB | ||
| 2012-07-17 17:40 |
VIVALIS ANNOUNCES A NEW EB66® CELL LINE RESEARCH LICENSE AGREEMENT WITH MERIAL …
|
English | 512.1 KB | ||
| 2012-07-05 17:46 |
VIVALIS : BILAN SEMESTRIEL CONTRAT DE LIQUIDITE
|
English | 218.3 KB | ||
| 2012-07-05 17:45 |
VIVALIS : ACTIONS ET DROIT DE VOTE JUIN 2012
|
English | 133.1 KB | ||
| 2012-07-03 17:40 |
VIVALIS ANNONCE LA SIGNATURE D'UNE NOUVELLE LICENCE DE RECHERCHE AVEC MERCK ANI…
|
French | 215.1 KB | ||
| 2012-07-03 17:40 |
VIVALIS ANNOUNCES A NEW EB66® CELL LINE RESEARCH LICENSE AGREEMENT WITH MERCK A…
|
English | 349.6 KB | ||
| 2012-06-20 17:40 |
VIVALIS ANNONCE LA SIGNATURE D'UN NOUVEL ACCORD DE LICENCE COMMERCIALE AVEC FAR…
|
French | 79.9 KB | ||
| 2012-06-20 17:40 |
VIVALIS ANNOUNCES A NEW EB66® CELL LINE COMMERCIAL LICENSE AGREEMENT WITH FARVE…
|
English | 74.0 KB | ||
| 2012-06-06 17:45 |
VIVALIS : ACTIONS ET DROITS DE VOTE MAI 2012
|
English | 133.0 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
